Immuo-Oncology Antibodies in the News
October 22, 2008
Corvus Pharmaceuticals is optimising a lead anti-CXCR2 antibody for cancer therapy.
Corvus Pharmaceuticals licensed an immuno-oncology program from Monash University.
Anti-C5aR Antibody in the News
Innate Pharma commenced a trial of its anti-C5aR antibody in COVID-19 patients.
Innate Pharma commenced a trial of its anti-C5aR antibody in patients with solid tumours.
Innate Pharma acquired an anti-C5aR antibody from Novo Nordisk A/S with plans to conduct clinical trials in oncology indications.
G2 & Novo Nordisk A/S announce the start of clinical trials (pdf, 100k)
February 8, 2006
G2 & Novo Nordisk A/S announce US$102m collaboration (pdf, 100k)